Closed call · historical reference
The opportunity funds the procurement of Rituximab biosimilar and is open to businesses and SMEs in Albania. The contracting authority is Operatori i Blerjeve te Perqendruara, with a total budget of approximately 176.76 million EUR.
Topics
Partner types
business, sme
